Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 3/20 | 0.51 |
| ▸ | CTSG | P08311 | 3/20 | 0.51 |
| ▸ | IAPP | P10997 | 4/20 | 0.46 |
| ▸ | HTR1A | P08908 | 1/20 | 0.46 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.44 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.44 |
| ▸ | BID | P55957 | 3/20 | 0.43 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.43 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.43 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.43 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.43 |
| ▸ | PPARG | P37231 | 1/20 | 0.43 |
| ▸ | PPARA | Q07869 | 1/20 | 0.43 |
| ▸ | EP300 | Q09472 | 1/20 | 0.43 |
| ▸ | KAT2A | Q92830 | 1/20 | 0.43 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.43 |
| ▸ | KAT5 | Q92993 | 1/20 | 0.43 |
| ▸ | SAE1 | Q9UBE0 | 1/20 | 0.43 |
| ▸ | ANPEP | P15144 | 1/20 | 0.42 |
| ▸ | DPP4 | P27487 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL982273 | 0.86 | ELANE (0.45) | ELANECTSGIAPPHTR1ABID | |
| SCHEMBL3932355 | 0.86 | ELANE (0.53) | ELANECTSGIAPPHTR1ABID | |
| SCHEMBL68921 | 0.82 | IAPP (0.65) | ELANECTSGIAPPGABRA1GABRB2 | |
| SCHEMBL3344675 | 0.81 | GABRA1 (0.61) | ELANECTSGIAPPGABRA1GABRB2 | |
| SCHEMBL30595395 | 0.81 | HTR1A (0.64) | HTR1AHSPA5 | |
| SCHEMBL51747 | 0.81 | HTR1A (0.64) | HTR1AHSPA5 | |
| SCHEMBL28615381 | 0.81 | ELANE (0.48) | ELANECTSGIAPPHTR1ABID | |
| SCHEMBL1039776 | 0.80 | TRPA1 (0.48) | ELANECTSGIAPPHTR1AGABRA1 | |
| SCHEMBL218408 | 0.80 | IAPP (0.44) | ELANECTSGIAPPHTR1AGABRA1 | |
| SCHEMBL31290573 | 0.80 | IAPP (0.44) | ELANECTSGIAPPHTR1AGABRA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9315435-B2 | Method for producing hydroxyphenylcyclohexanol compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-04-19 | — | — | US | disclosed |
| US-20150141707-A1 | METHOD FOR PRODUCING HYDROXYPHENYLCYCLOHEXANOL COMPOUND | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2015-05-21 | — | — | US | disclosed |
| EP-2842930-A1 | METHOD FOR PRODUCING HYDROXYPHENYLCYCLOHEXANOL COMPOUND | Sumitomo Chemical Company Limited (JP) | 2015-03-04 | — | — | EP | disclosed |
| EP-1586598-B1 | Process for preparation of polymeric, phosphorus-containing compositions | INVISTA TECH SARL (CH) | 2009-09-09 | — | — | EP | disclosed |
| EP-1586598-A1 | Process for preparation of polymeric, phosphorus-containing compositions | E.I. du Pont de Nemours and Company (US) | 2005-10-19 | — | — | EP | disclosed |
| EP-1571172-A1 | Polymeric, phosphorus-containing compositions and their use in hydrocyanation, isomerization and hydroformylation reactions | E.I. du Pont de Nemours and Company (US) | 2005-09-07 | — | — | EP | disclosed |
| EP-1448668-A1 | POLYMERIC, PHOSPHOROUS-CONTAINING COMPOSITIONS AND THEIR USE IN HYDROCYANATION, ISOMERIZATION AND HYDROFORMYLATION REACTIONS | E. I. du Pont de Nemours and Company (US) | 2004-08-25 | — | — | EP | disclosed |
| US-20030135014-A1 | Polymeric, phosphorus-containing compositions and their use in hydrocyanation, isomerization and hydroformylation reactions | INVISTA NORTH AMERICA S.A.R.L. | 2003-07-17 | — | — | US | disclosed |
| WO-2003046049-A1 | POLYMERIC, PHOSPHOROUS-CONTAINING COMPOSITIONS AND THEIR USE IN HYDROCYANATION, ISOMERIZATION AND HYDROFORMYLATION REACTIONS | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 2003-06-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150141707-A1 | METHOD FOR PRODUCING HYDROXYPHENYLCYCLOHEXANOL COMPOUND | HSD11B2, CYP21A2, CYP11B2 | ELANE 1834/4885CTSG 4431/4885IAPP 2629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.